Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 16
2003 19
2004 25
2005 39
2006 31
2007 45
2008 47
2009 70
2010 61
2011 64
2012 96
2013 103
2014 104
2015 105
2016 113
2017 118
2018 155
2019 168
2020 204
2021 244
2022 288
2023 291
2024 276
2025 366
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,714 results

Results by year

Filters applied: . Clear all
Page 1
CHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma.
Zhang X, Duan S, Apostolou PE, Wu X, Watanabe J, Gallitto M, Barron T, Taylor KR, Woo PJ, Hua X, Zhou H, Wei HJ, McQuillan N, Kang KD, Friedman GK, Canoll PD, Chang K, Wu CC, Hashizume R, Vakoc CR, Monje M, McKhann GM 2nd, Gogos JA, Zhang Z. Zhang X, et al. Among authors: zhou h. Cancer Discov. 2024 Sep 4;14(9):1732-1754. doi: 10.1158/2159-8290.CD-23-0012. Cancer Discov. 2024. PMID: 38767413 Free PMC article.
SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters.
Chen M, Yuan L, Chen B, Chang H, Luo J, Zhang H, Chen Z, Kong J, Yi Y, Bai M, Dong M, Zhou H, Jiang H. Chen M, et al. Among authors: zhou h. Nat Commun. 2025 Jan 30;16(1):1181. doi: 10.1038/s41467-025-56402-y. Nat Commun. 2025. PMID: 39885119 Free PMC article.
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study.
Zhao P, Zhao S, Huang C, Li Y, Wang J, Xu J, Li L, Qian Z, Li W, Zhou S, Qiu L, Liu X, Chen Y, Jiang Y, Zheng Y, Chen D, Zhou H, Gao Y, Zhang Q, Zhang H. Zhao P, et al. Among authors: zhou h. Hematol Oncol. 2025 Jan;43(1):e70017. doi: 10.1002/hon.70017. Hematol Oncol. 2025. PMID: 39641321
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
Li Z, Jiang W, Zhou H, Cen H, Zhang M, Lv F, Zhang Q, Sun X, Liu L, Huang Y, Yang H, Gao S, He C, Yang W, Li W, Yu D, Yang Y, Cheng Y, Qian Z, Xiang Y, Guo Q, Xu B, Song Y, Zhang L, Lin L, Shen J, Yan F, Liu H, Zhang D, Wang J, Zhou M, Zhu X, Zhang W, Zhao W, Feng R, Zhang X, Jin J, Zhong M, Zhang M, Wang J, Jing H, Wang Z, Zhao H, Zhu J. Li Z, et al. Among authors: zhou h. J Immunother Cancer. 2024 Oct 24;12(10):e008895. doi: 10.1136/jitc-2024-008895. J Immunother Cancer. 2024. PMID: 39455094 Free PMC article. Clinical Trial.
2,714 results